|
[1]
|
Effect of Flavonoids against Parkinson’s Disease
Central Nervous System Agents in Medicinal Chemistry,
2024
DOI:10.2174/0118715249264078231214074107
|
|
|
|
|
[2]
|
Malvidin-3-O-Glucoside Mitigates α-Syn and MPTP Co-Induced Oxidative Stress and Apoptosis in Human Microglial HMC3 Cells
International Journal of Molecular Sciences,
2024
DOI:10.3390/ijms252312733
|
|
|
|
|
[3]
|
Anthocyanins: Metabolic Digestion, Bioavailability, Therapeutic Effects, Current Pharmaceutical/Industrial Use, and Innovation Potential
Antioxidants,
2022
DOI:10.3390/antiox12010048
|
|
|
|
|
[4]
|
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Biochemical Pharmacology,
2022
DOI:10.1016/j.bcp.2022.115257
|
|
|
|
|
[5]
|
Anthocyanins: Metabolic Digestion, Bioavailability, Therapeutic Effects, Current Pharmaceutical/Industrial Use, and Innovation Potential
Antioxidants,
2022
DOI:10.3390/antiox12010048
|
|
|
|
|
[6]
|
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Biochemical Pharmacology,
2022
DOI:10.1016/j.bcp.2022.115257
|
|
|
|
|
[7]
|
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Biochemical Pharmacology,
2022
DOI:10.1016/j.bcp.2022.115257
|
|
|
|
|
[8]
|
Behavioral Pharmacology - From Basic to Clinical Research [Working Title]
2019
DOI:10.5772/intechopen.90428
|
|
|
|